MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1

Abstract

microRNA-155 works as a promoter in the atherosclerotic procession. Its mechanism may include enhancing inflammatory response in atherosclerosis by increasing STAT3 and NF-κB signaling via targeting SOCS1.